A groundbreaking drug , retatrutide, is sparking considerable buzz within the Aussie weight loss community. Created by Eli Lilly , this twin GIP and GLP-1 receiver appears to deliver more substantial benefits than current therapies. Initial medical trials have shown exceptional reductions in body mass, raising a for a innovative approach to address